Marco Garca - Farmacias Benavides IT Director
BEVIDESB | MXN 23.00 0.00 0.00% |
Insider
Marco Garca is IT Director of Farmacias Benavides SAB
Phone | 52 81 8150 7700 |
Web | https://www.benavides.com.mx |
Farmacias Benavides Management Efficiency
The company has return on total asset (ROA) of 0.0629 % which means that it generated a profit of $0.0629 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.9238 %, meaning that it generated $0.9238 on every $100 dollars invested by stockholders. Farmacias Benavides' management efficiency ratios could be used to measure how well Farmacias Benavides manages its routine affairs as well as how well it operates its assets and liabilities.Farmacias Benavides SAB has accumulated 1.25 B in total debt with debt to equity ratio (D/E) of 301.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Farmacias Benavides SAB has a current ratio of 1.06, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Farmacias Benavides until it has trouble settling it off, either with new capital or with free cash flow. So, Farmacias Benavides' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Farmacias Benavides SAB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Farmacias to invest in growth at high rates of return. When we think about Farmacias Benavides' use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
Matt Smith | Lloyds Banking Group | N/A | |
Zachary Sopcak | UnitedHealth Group Incorporated | N/A | |
Jose Celorio | Grupo Sports World | 39 | |
Sandeep Dadlani | UnitedHealth Group Incorporated | 48 | |
Tatiana Stead | Capital One Financial | N/A | |
Eduardo Cunha | Lloyds Banking Group | 60 | |
Fabian Bifaretti | Grupo Sports World | 59 | |
Jennifer Smoter | UnitedHealth Group Incorporated | N/A | |
William Chalmers | Lloyds Banking Group | 55 | |
Rupert Bondy | UnitedHealth Group Incorporated | 61 | |
Jeff Norris | Capital One Financial | N/A | |
James Barry | UnitedHealth Group Incorporated | 77 | |
Tamara Erwin | Verizon Communications | 58 | |
Carla Silva | Lloyds Banking Group | 49 | |
Sir Witty | UnitedHealth Group Incorporated | 58 | |
Andrew Young | Capital One Financial | 48 | |
CPA CFA | First Republic Bank | N/A | |
F McNabb | UnitedHealth Group Incorporated | 61 | |
John Chambers | Lloyds Banking Group | N/A | |
Catherine Cheetham | Lloyds Banking Group | 60 | |
Letitia Smith | Lloyds Banking Group | 57 |
Management Performance
Return On Equity | 0.92 | |||
Return On Asset | 0.0629 |
Farmacias Benavides SAB Leadership Team
Elected by the shareholders, the Farmacias Benavides' board of directors comprises two types of representatives: Farmacias Benavides inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Farmacias. The board's role is to monitor Farmacias Benavides' management team and ensure that shareholders' interests are well served. Farmacias Benavides' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Farmacias Benavides' outside directors are responsible for providing unbiased perspectives on the board's policies.
Marco Garca, IT Director | ||
Macedonio Hernandez, Chairman of the Board, CEO | ||
Enrique HinojosaGallaga, Sec | ||
Manuel Garca, Sales North | ||
Luis Demis, F Director |
Farmacias Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Farmacias Benavides a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.92 | |||
Return On Asset | 0.0629 | |||
Profit Margin | 0 % | |||
Operating Margin | 0.05 % | |||
Current Valuation | 6.36 B | |||
Shares Outstanding | 358.84 M | |||
Shares Owned By Insiders | 95.60 % | |||
Price To Book | 20.47 X | |||
Price To Sales | 0.21 X | |||
Revenue | 14.74 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Farmacias Stock Analysis
When running Farmacias Benavides' price analysis, check to measure Farmacias Benavides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Farmacias Benavides is operating at the current time. Most of Farmacias Benavides' value examination focuses on studying past and present price action to predict the probability of Farmacias Benavides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Farmacias Benavides' price. Additionally, you may evaluate how the addition of Farmacias Benavides to your portfolios can decrease your overall portfolio volatility.